Literature DB >> 11049791

Community-acquired pneumonia in the elderly.

T J Marrie1.   

Abstract

Pneumonia in the elderly is a common and serious problem with a clinical presentation that can differ from that in younger patients. Older patients with pneumonia complain of significantly fewer symptoms than do younger patients, and delirium commonly occurs. Indeed, delirium may be the only manifestation of pneumonia in this group of patients. Alcoholism, asthma, immunosuppression, and age >70 years are risk factors for community-acquired pneumonia in the elderly. Among nursing home residents, the following are risk factors for pneumonia: advanced age, male sex, difficulty in swallowing, inability to take oral medications, profound disability, bedridden state, and urinary incontinence. Streptococcus pneumoniae is the most common cause of pneumonia among the elderly. Aspiration pneumonia is underdiagnosed in this group of patients, and tuberculosis always should be considered. In this population an etiologic diagnosis is rarely available when antimicrobial therapy must be instituted. Use of the guidelines for treatment of pneumonia issued by the Infectious Diseases Society of America, with modification for treatment in the nursing home setting, is recommended.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049791     DOI: 10.1086/318124

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  60 in total

1.  Severe pneumonia in the elderly: a multivariate analysis of risk factors.

Authors:  Wei Li; Cheng Ding; Shaojun Yin
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Infection control issues in older adults.

Authors:  Lona Mody
Journal:  Clin Geriatr Med       Date:  2007-08       Impact factor: 3.076

3.  Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study.

Authors:  Ruth Gil-Prieto; Raquel Pascual-Garcia; Stefan Walter; Alejandro Álvaro-Meca; Ángel Gil-De-Miguel
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 4.  South African guideline for the management of community-acquired pneumonia in adults.

Authors:  Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

5.  Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65.

Authors:  Zoe Xiaozhu Zhang; Yang Yong; Wan C Tan; Liang Shen; Han Seong Ng; Kok Yong Fong
Journal:  Singapore Med J       Date:  2017-08-14       Impact factor: 1.858

Review 6.  Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.

Authors:  T T Dang; S R Majumdar; T J Marrie; D T Eurich
Journal:  Drugs Aging       Date:  2015-01       Impact factor: 3.923

Review 7.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

8.  Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study.

Authors:  Binod Neupane; Stephen D Walter; Paul Krueger; Tom Marrie; Mark Loeb
Journal:  BMC Geriatr       Date:  2010-05-11       Impact factor: 3.921

9.  Clonal distribution of invasive pneumococci, Czech Republic, 1996-2003.

Authors:  Helena Zemlickova; Pavla Urbaskova; Vladislav Jakubu; Jitka Motlova; Martin Musilek; Bohumir Prochazka
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

10.  Rationale and design of the CAPAMIS study: effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke.

Authors:  Angel Vila-Corcoles; Inmaculada Hospital-Guardiola; Olga Ochoa-Gondar; Cinta de Diego; Elisabet Salsench; Xavier Raga; Cruz M Fuentes-Bellido
Journal:  BMC Public Health       Date:  2010-01-19       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.